Imaging of Myeloma Bone Disease - Implications for Staging, Prognosis and Follow-up

By Dimopoulos Meletios A.   Moulopoulos Lia A.   Datseris Ioannis   Weber Donna   Delasalle Kay   Gika Dimitra   Alexanian Raymond  

Acta Oncologica, Vol. 39, Iss. 7, 2000-11 ,pp. : 823-827

Informa Healthcare

Access to resources Recommend Favorite

The cytotoxic T cell response to peptide analogs of the HLA-A*0201-restricted MUC1 signal sequence epitope, M1.2

By Mitchell Malcolm   Lund Teri   Sewell Andrew   Marincola Francesco   Paul Elyse   Schroder Kim   Wilson Darcy   Kan-Mitchell June  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 3, 2007-03 ,pp. : 287-301

Springer Publishing Company

Access to resources Recommend Favorite

Treatment options for multiple myeloma patients with high-risk disease

By Ailawadhi Sikander   Masood Aisha   Sher Taimur   Miller Kena   Wood Margaret   Lee Kelvin   Chanan-Khan Asher  

Medical Oncology, Vol. 27, Iss. 1, 2010-06 ,pp. : 53-61

Humana Press, Inc

Access to resources Recommend Favorite

Management of disease- and treatment-related complications in patients with multiple myeloma

By Gay Francesca   Palumbo Antonio  

Medical Oncology, Vol. 27, Iss. 1, 2010-06 ,pp. : 43-52

Humana Press, Inc

Access to resources Recommend Favorite

Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease

By Hungria Vania   Latrilha Maria   Rodrigues Debora   Bydlowski Sergio   Chiattone Carlos   Maranhão Raul  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 1, 2004-01 ,pp. : 51-60

Springer Publishing Company

Access to resources Recommend Favorite